SonoSite Applauds White Memorial Medical Center for Boosting Patient Safety Levels by Reducing Central Line-Associated Blood

  SonoSite Applauds White Memorial Medical Center for Boosting Patient Safety
  Levels by Reducing Central Line-Associated Blood Stream Infections and
  Pneumothoraces to Zero

 SonoSite Acknowledges WMMC with Distinguished Star Award for its Continuous
        Commitment to Central-Line Safety and Outstanding Patient Care

Business Wire

BOTHELL, Wash. -- August 29, 2013

FUJIFILM SonoSite Inc., international specialists, manufacturers, and
educators in portable, point-of-care ultrasound systems, announced an
outstanding patient-safety achievement by White Memorial Medical Center
(WMMC), a 353-bed not-for-profit teaching hospital affiliated with the
Adventist Health System located in downtown Los Angeles, CA. Since 2011, the
institution has achieved a hospital-wide zero iatrogenic pneumothorax
complication rate during central line catheterizations (CVCs). During this
same period, it has maintained a zero central line-associated infections
(CLABSI) rate in its intensive care unit. WMMC achieved these results by
introducing the SonoSite Central Line Management Training Program, which ran
from January 2010 through August 2011.

In recognition of this accomplishment, the medical center was awarded
SonoSite's distinguished Star Award. “We applaud White Memorial Medical Center
for their success in implementing a high standard for eliminating serious
iatrogenic complications," said Kevin M. Goodwin, President and CEO, FUJIFILM
SonoSite Inc. "Outstanding accomplishments never occur without commitment and
active involvement. White Memorial has demonstrated its dedication to
excellence and patient safety.”

The onsite SonoSite Central Line Management Training Program as implemented at
WMMC includes many instructional elements, such as hospital-wide training
related to best practices for inserting central lines; “train the trainer”
sessions; and a quality assurance feedback process. Integral to the program is
the teaching of a five-point central-line bundle with proven safety measures
by the Institute of Healthcare Improvement (IHI), a protocol which has been
shown to decrease the rate of CLABSI when carefully followed^1.

The SonoSite Central Line Management Training Program teaches the IHI bundle
plus an additional sixth step: ultrasound needle guidance for line placements.
Research has shown that, by using ultrasound to aid in guiding the needle
during a central line placement, the risk for cannulation failure, accidental
arterial puncture, hematoma, pneumothorax, and other complications is
decreased^2.

It should be noted, however, that while research indicates the implementation
of central-line bundles can lower CLABSI rates in ICUs, even the best bundles
will fail to effect adequate change if hospitals don't strongly target
rigorous compliance^1. Project administrators at White Memorial Medical Center
recognized this need for more than simply instituting guidelines when they
launched their training program. "It was clear that if you got the right tools
and the teaching and you were able to change the culture, it would become part
of your practice," said Angela Hughes, RN, BSN, MSN, Director, Continuum of
Care. "That’s what we were shooting for. SonoSite was integral to this
process."

WMMC administrators who watched their rates of CVC mechanical failures and
CLABSI plummet during and following the Central Line Management Training
Program have been more than satisfied with program results. "The numbers
really do speak for themselves about the program's effectiveness. I’ve learned
through this project that you can achieve zero," said Mara Bryant, Sr. Vice
President, Organizational Excellence.

WMMC is the second hospital to receive the Star Award from SonoSite for
outstanding achievements in patient safety. The Memorial Hermann Healthcare
System of Houston, TX, was the first. Memorial Hermann also achieved a zero
rate of iatrogenic pneumothoraces after implementing ultrasound guidance for
central line placements.

SonoSite is committed to quality care, and it partners with healthcare
facilities to achieve patient safety goals. For more information, please click
here.

About White Memorial Medical Center

White Memorial Medical Center (WMMC) is a 353-bed not-for-profit, faith-based,
teaching hospital, which provides a full range of inpatient, outpatient,
emergency and diagnostic services to communities in and near downtown Los
Angeles. Keeping our communities healthy has been the mission of White
Memorial Medical Center ever since the hospital was founded by the Seventh-day
Adventist Church in 1913. Today, White Memorial is one of the region's leading
not-for-profit hospitals. Services include behavioral medicine, cardiac and
vascular care, intensive and general medical care, oncology, orthopedic care,
rehabilitation, specialized and general surgery, and women’s and children’s
services. As a major teaching hospital, White Memorial also plays an important
role in training physicians, nurses and other medical professionals.

About:

FUJIFILM SonoSite, Inc., is the innovator and world leader in bedside and
point-of-care ultrasound, and an industry leader in ultra high-frequency
micro-ultrasound technology. Headquartered near Seattle, the company is
represented by 26 subsidiaries and a global distribution network in over 100
countries. SonoSite’s portable, compact systems are expanding the use of
ultrasound across the clinical spectrum by cost-effectively bringing
high-performance ultrasound to the point of patient care. For more
information, go to: www.sonosite.com.

FUJIFILM Holdings Corporation, Tokyo, Japan, brings continuous innovation and
leading-edge products to a broad spectrum of industries, including electronic
imaging, digital printing equipment, medical systems, life sciences, graphic
arts, flat panel display materials, and office products, based on a vast
portfolio of digital, optical, fine chemical and thin film coating
technologies. The company was among the top 10 companies around the world
granted U.S. patents in 2012, and in the year ended March 31, 2013, had global
revenues of $26.7 billion*. Fujifilm is committed to environmental stewardship
and good corporate citizenship. For more information, please visit
www.fujifilmholdings.com.

* At an exchange rate of 83 yen to the dollar.

  All product and company names herein may be trademarks of their registered
                                   owners.

Clinical Evidence and Sources:

1. Furuya EY, Dick A, Perencevich EN, et al. (2011) Central Line Bundle
Implementation in US Intensive Care Units and Impact on Bloodstream
Infections. PLoS ONE 6(1): e15452. doi:10.1371/journal.pone.0015452

2. Wu S-Y, Ling Q, et al. Real-time two-dimensional ultrasound guidance for
central venous cannulation: A meta-analysis. Anesthesiology 2013 Feb; 118:372.

Contact:

FUJIFILM SonoSite, Inc.
Lisa Ault, 516-282-4590
Lisa.ault@sonosite.com
 
Press spacebar to pause and continue. Press esc to stop.